Dr Kent's Neurowellness clinic

Dr Kent's Neurowellness clinic This page advertises the Neurowellness clinic and ongoing research at the facility as well as it encourages validated approaches to Neuro wellness .

In 1991, after graduating from Oklahoma University medical school, I entered Neurological residency. After serving as chief resident I entered a rural practice serving a five County area. As a general neurologist I treated everything from sleep disorders, muscular dystrophy, ALS, multiple sclerosis, migraine, Alzheimer’s, brain tumors, neuropathy, epilepsy and chronic pain.In 1998 started working in an integrative health/patient centered approach.Now I am working in public health,clinical research and bioinformatics. In 2008 I developed chronic illness and pain. After the failure of surgery and pharmaceuticals to help me return to health, I turned to herbal therapy, mindfulness and acupuncture. It worked for my pain and I turned my personal life from a rat race to a happy one. I started
In 2010 I moved back to Oklahoma to be near my family and friends. I am active on the local seminar circuit, webinars, social media and advocacy groups. I enjoy every day because I wake up and know I will get to help someone find a new opportunity for improved health.

02/13/2026

Dr. Kent Smalley and the Neuro wellness clinic are able to take patients again after a brief period when we were full because of the number of patients wanting therapy. We are taking new Medicare patients. Our clinic specializes in providing Alzheimer's patients with anti-amyloid therapy medications designed to target and reduce amyloid plaques in the brain which are linked to the progression of Alzheimer's disease. These FDA approved treatments for the early stages of Alzheimer's as well as other treatments and clinical trials are the focus of our clinic. If you have Medicare and are interested in these treatments, please contact us at 405-696-3773.

Oral semaglutide fails to slow clinical progression, but biomarker changes emerge
11/25/2025

Oral semaglutide fails to slow clinical progression, but biomarker changes emerge

Diet can reduce Alzheimer’s risk even in E4 patients
08/26/2025

Diet can reduce Alzheimer’s risk even in E4 patients

Adhering to a Mediterranean diet modulated dementia-related metabolites in APOE4 carriers

Subcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New Data and 4 year IV data shows continued benef...
08/03/2025

Subcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New Data and 4 year IV data shows continued benefits

Four-year outcomes for IV treatment show continued benefits

FDA Clears First Blood Test for Alzheimer's Diagnosis— Plasma assessment is not intended as a screening or stand-alone d...
05/16/2025

FDA Clears First Blood Test for Alzheimer's Diagnosis
— Plasma assessment is not intended as a screening or stand-alone diagnostic test, agency says

Plasma assessment is not intended as a screening or stand-alone diagnostic test, agency says

Alzheimer's Patients May Gain Months of Independent Living With Treatment— Model estimates how long lecanemab and donane...
02/21/2025

Alzheimer's Patients May Gain Months of Independent Living With Treatment
— Model estimates how long lecanemab and donanemab might extend functional independence

Model estimates how long lecanemab and donanemab might extend functional independence

Dementia risk may be twice as high as Americans live longer, study finds
01/14/2025

Dementia risk may be twice as high as Americans live longer, study finds

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in the U.S. is expected to double by 2060.

Novel Cell-Based Therapy Promising for Alzheimer's Disease
09/05/2024

Novel Cell-Based Therapy Promising for Alzheimer's Disease

An experimental cell-based therapy improved cognitive function, quality of life, and brain volume in adults with mild Alzheimer's disease.

Industry Study Finds Lecanemab Shows Continued Benefit After Three Years of Treatment
08/15/2024

Industry Study Finds Lecanemab Shows Continued Benefit After Three Years of Treatment

An abstract is unavailable.

Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients— Brain markers of degeneration, injury were bette...
08/13/2024

Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients
— Brain markers of degeneration, injury were better, too

Brain markers of degeneration, injury were better, too

I Didn't Truly Understand Opioid Addiction Until It Killed My Son
05/08/2024

I Didn't Truly Understand Opioid Addiction Until It Killed My Son

Despite being a doctor, I learned too late that substance use disorder is a treatable disease

Address

3432 NW 178th
Edmond, OK
73012

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+14056963773

Website

Alerts

Be the first to know and let us send you an email when Dr Kent's Neurowellness clinic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr Kent's Neurowellness clinic:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category